Bloomberg Law
April 14, 2021, 7:59 PM UTCUpdated: April 14, 2021, 9:47 PM UTC

J&J Vaccine Liability Shield a Boon Despite Rare Blood Clots (1)

Ian Lopez
Ian Lopez
Senior Reporter
Jacquie Lee
Jacquie Lee
Reporter

Johnson & Johnson, AstraZeneca plc, and other Covid-19 vaccine makers are shielded from liability for adverse effects on recipients, and attorneys say the protections are a boon for medical innovation that’s critical to combating the pandemic.

A vaccine advisory panel for the Centers for Disease Control and Prevention met on Wednesday to discuss how to move forward with the J&J vaccine after seven women developed rare and dangerous blood clots following their shots. The CDC’s Advisory Committee on Immunization Practices didn’t make a recommendation and said it will find a time to reconvene—leaving the vaccine on pause.

U.S. ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.